Alnylam Pharmaceuticals
ALNY
#799
Rank
ยฃ23.33 B
Marketcap
ยฃ174.43
Share price
2.47%
Change (1 day)
-51.33%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company